China FDA notes meeting with U.S. counterparts, but no details

SINGAPORE--China and U.S. drug officials held their first working meeting of the year recently, China's FDA revealed, but it offered no information other than the general matters discussed.

A short China FDA notice said the two agencies discussed inspections for good manufacturing practices carried out last year, their bilateral cooperation in high-level meetings and the year's personnel exchanges. They also "discussed the tasks of 2015," the notice said.

The discussions, which were held Feb. 11, were attended by officials of the CFDA's Department of International Cooperation and the U.S. FDA's China office.

- read the CFDA notice here

Related Stories:
FDA Commissioner to talk drug safety with top Chinese officials
FDA bans maker of suspect Chinese heparin
The FDA is stationing 10 new drug inspectors in China